mRNA |
cyanoquinoline 11 |
CTRPv2 |
pan-cancer |
AAC |
0.032 |
0.6 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
purmorphamine |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.6 |
mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
BRD-K79669418 |
CTRPv2 |
pan-cancer |
AAC |
0.033 |
0.6 |
mRNA |
Erlotinib |
UHNBreast |
pan-cancer |
AAC |
-0.16 |
0.6 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.6 |
mRNA |
KU-60019 |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
BRD-K27224038 |
CTRPv2 |
pan-cancer |
AAC |
0.046 |
0.6 |